|
1
|
Guttman M, Amit I, Garber M, French C, Lin
MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, et al:
Chromatin signature reveals over a thousand highly conserved large
non-coding RNAs in mammals. Nature. 458:223–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Qureshi IA and Mehler MF: Emerging roles
of non-coding RNAs in brain evolution, development, plasticity and
disease. Nat Rev Neurosci. 13:528–541. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Calore F, Lovat F and Garofalo M:
Non-coding RNAs and cancer. Int J Mol Sci. 14:17085–17110. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rinn JL and Chang HY: Genome regulation by
long noncoding RNAs. Annu Rev Biochem. 81:145–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao Y, Li H, Fang S, Kang Y, Wu W, Hao Y,
Li Z, Bu D, Sun N, Zhang MQ and Chen R: NONCODE 2016: An
informative and valuable data source of long non-coding RNAs.
Nucleic Acids Res. 44(D1): D203–D208. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li S, Li B, Zheng Y, Li M, Shi L and Pu X:
Exploring functions of long noncoding RNAs across multiple cancers
through co-expression network. Sci Rep. 7:7542017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Long Y, Wang X, Youmans DT and Cech TR:
How do lncRNAs regulate transcription? Sci Adv. 3:eaao21102017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang X, Zhou Y, Mehta KR, Danila DC,
Scolavino S, Johnson SR and Klibanski A: A pituitary-derived MEG3
isoform functions as a growth suppressor in tumor cells. J Clin
Endocrinol Metab. 88:5119–5126. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang J, Yao T, Wang Y, Yu J, Liu Y and
Lin Z: Long noncoding RNA MEG3 is downregulated in cervical cancer
and affects cell proliferation and apoptosis by regulating miR-21.
Cancer Biol Ther. 17:104–113. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang P, Ren Z and Sun P: Overexpression of
the long non-coding RNA MEG3 impairs in vitro glioma cell
proliferation. J Cell Biochem. 113:1868–1874. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Luo G, Wang M, Wu X, Tao D, Xiao X, Wang
L, Min F, Zeng F and Jiang G: Long non-coding RNA MEG3 inhibits
cell proliferation and induces apoptosis in prostate cancer. Cell
Physiol Biochem. 37:2209–2220. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dai X, Li T, Bai Z, Yang Y, Liu X, Zhan J
and Shi B: Breast cancer intrinsic subtype classification, clinical
use and future trends. Am J Cancer Res. 5:2929–2943.
2015.PubMed/NCBI
|
|
18
|
Abramson VG, Lehmann BD, Ballinger TJ and
Pietenpol JA: Subtyping of triple-negative breast cancer:
Implications for therapy. Cancer. 121:8–16. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang JJ, Guo SH and Jia BQ:
Down-regulation of long non-coding RNA MEG3 serves as an
unfavorable risk factor for survival of patients with breast
cancer. Eur Rev Med Pharmacol Sci. 20:5143–5147. 2016.PubMed/NCBI
|
|
20
|
Tian T, Wang M, Lin S, Guo Y, Dai Z, Liu
K, Yang P, Dai C, Zhu Y, Zheng Y, et al: The impact of lncRNA
dysregulation on clinicopathology and survival of breast cancer: A
systematic review and meta-analysis. Mol Ther Nucleic Acids.
12:359–369. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cui X, Yi Q, Jing X, Huang Y, Tian J, Long
C, Xiang Z, Liu J, Zhang C, Tan B, et al: Mining prognostic
significance of MEG3 in human breast cancer using bioinformatics
analysis. Cell Physiol Biochem. 50:41–51. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang CY, Yu MS, Li X, Zhang Z, Han CR and
Yan B: Overexpression of long non-coding RNA MEG3 suppresses breast
cancer cell proliferation, invasion, and angiogenesis through AKT
pathway. Tumour Biol. 39:10104283177013112017.PubMed/NCBI
|
|
23
|
Sun L, Li Y and Yang B: Downregulated long
non-coding RNA MEG3 in breast cancer regulates proliferation,
migration and invasion by depending on p53's transcriptional
activity. Biochem Biophys Res Commun. 478:323–329. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ran FA, Hsu PD, Wright J, Agarwala V,
Scott DA and Zhang F: Genome engineering using the CRISPR-Cas9
system. Nat Protoc. 8:2281–2308. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sánchez-Rivera FJ and Jacks T:
Applications of the CRISPR-Cas9 system in cancer biology. Nat Rev
Cancer. 15:387–395. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang H, La Russa M and Qi LS: CRISPR/Cas9
in genome editing and beyond. Annu Rev Biochem. 85:227–264. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu SJ, Horlbeck MA, Cho SW, Birk HS,
Malatesta M, He D, Attenello FJ, Villalta JE, Cho MY, Chen Y, et
al: CRISPRi-based genome-scale identification of functional long
noncoding RNA loci in human cells. Science. 355(pii): aah71112017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen W, Zhang G, Li J, Zhang X, Huang S,
Xiang S, Hu X and Liu C: CRISPRlnc: A manually curated database of
validated sgRNAs for lncRNAs. Nucleic Acids Res. 47:D63–D68. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Goyal A, Myacheva K, Groß M, Klingenberg
M, Duran Arqué B and Diederichs S: Challenges of CRISPR/Cas9
applications for long non-coding RNA genes. Nucleic Acids Res.
45:e122017.PubMed/NCBI
|
|
30
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou Y, Zhang X and Klibanski A: MEG3
noncoding RNA: A tumor suppressor. J Mol Endocrinol. 48:R45–R53.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Olson MF and Sahai E: The actin
cytoskeleton in cancer cell motility. Clin Exp Metastasis.
26:273–287. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Terashima M, Tange S, Ishimura A and
Suzuki T: MEG3 long noncoding RNA contributes to the epigenetic
regulation of epithelial-mesenchymal transition in lung cancer cell
lines. J Biol Chem. 292:82–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xia Y, He Z, Liu B, Wang P and Chen Y:
Downregulation of Meg3 enhances cisplatin resistance of lung cancer
cells through activation of the WNT/β-catenin signaling pathway.
Mol Med Rep. 12:4530–4537. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu J, Wan L, Lu K, Sun M, Pan X, Zhang P,
Lu B, Liu G and Wang Z: The long noncoding RNA MEG3 contributes to
cisplatin resistance of human lung adenocarcinoma. PLoS One.
10:e01145862015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao H, Wang X, Feng X, Li X, Pan L, Liu
J, Wang F, Yuan Z, Yang L, Yu J, et al: Long non-coding RNA MEG3
regulates proliferation, apoptosis and autophagy and is associated
with prognosis in glioma. J Neurooncol. 140:281–288. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shi Y, Lv C, Shi L and Tu G: MEG3 inhibits
proliferation and invasion and promotes apoptosis of human
osteosarcoma cells. Oncol Lett. 15:1917–1923. 2018.PubMed/NCBI
|
|
38
|
Miyoshi N, Wagatsuma H, Wakana S,
Shiroishi T, Nomura M, Aisaka K, Kohda T, Surani MA, Kaneko-Ishino
T and Ishino F: Identification of an imprinted gene, Meg3/Gtl2 and
its human homologue MEG3, first mapped on mouse distal chromosome
12 and human chromosome 14q. Genes Cells. 5:211–220. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhou Y, Cheunsuchon P, Nakayama Y, Lawlor
MW, Zhong Y, Rice KA, Zhang L, Zhang X, Gordon FE, Lidov HG, et al:
Activation of paternally expressed genes and perinatal death caused
by deletion of the Gtl2 gene. Development. 137:2643–2652. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhou Y, Zhong Y, Wang Y, Zhang X, Batista
DL, Gejman R, Ansell PJ, Zhao J, Weng C and Klibanski A: Activation
of p53 by MEG3 non-coding RNA. J Biol Chem. 282:24731–24742. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang X, Rice K, Wang Y, Chen W, Zhong Y,
Nakayama Y, Zhou Y and Klibanski A: Maternally expressed gene 3
(MEG3) noncoding ribonucleic acid: Isoform structure, expression,
and functions. Endocrinology. 151:939–947. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tang Y, He Y, Zhang P, Wang J, Fan C, Yang
L, Xiong F, Zhang S, Gong Z, Nie S, et al: LncRNAs regulate the
cytoskeleton and related Rho/ROCK signaling in cancer metastasis.
Mol Cancer. 17:772018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang C, Yan G, Zhang Y, Jia X and Bu P:
Long non-coding RNA MEG3 suppresses migration and invasion of
thyroid carcinoma by targeting of Rac1. Neoplasma. 62:541–549.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Parri M and Chiarugi P: Rac and Rho
GTPases in cancer cell motility control. Cell Commun Signal.
8:232010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Mitra R, Chen X, Greenawalt EJ, Maulik U,
Jiang W, Zhao Z and Eischen CM: Decoding critical long non-coding
RNA in ovarian cancer epithelial-to-mesenchymal transition. Nat
Commun. 8:16042017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mondal T, Subhash S, Vaid R, Enroth S,
Uday S, Reinius B, Mitra S, Mohammed A, James AR, Hoberg E, et al:
MEG3 long noncoding RNA regulates the TGF-β pathway genes through
formation of RNA-DNA triplex structures. Nat Commun. 6:77432015.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Housman G, Byler S, Heerboth S, Lapinska
K, Longacre M, Snyder N and Sarkar S: Drug resistance in cancer: An
overview. Cancers (Basel). 6:1769–1792. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li ZY, Yang L, Liu XJ, Wang XZ, Pan YX and
Luo JM: The long noncoding RNA MEG3 and its target miR-147 regulate
JAK/STAT pathway in advanced chronic myeloid leukemia.
EBioMedicine. 34:61–75. 2018. View Article : Google Scholar : PubMed/NCBI
|
